Cancer or precancer testing using DNA sequencing results
Part of Blood & lymphatic, Brain & nervous system, Cancer, Digestive system, Hormones & metabolism, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This trial helps doctors study and analyze cancer- or precancer-related DNA information. If you’re 18 or older and can consent, your results may help researchers understand the biology of your condition and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Be getting checked for a precancer condition or already have cancer
- Read and sign the study consent form voluntarily
- Be able to understand the consent form and study steps
- Not have a mental health condition that would make consent or following study steps difficult
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new blood test can detect multiple types of cancer early by analyzing DNA fragments in your blood. Researchers are enrolling people recently diagnosed with cancer (before treatment starts) and people without cancer to develop and validate this detection method.
This study looks at whether DNA (from a tumor or related samples) can help identify inherited cancer risk in people who develop cancer at a young age. It may help families learn more about risk factors and guide future screening or prevention.
This study collects samples from your cancer (like during surgery or a biopsy) to grow tiny lab “organoids” for testing. It may help researchers learn which treatments could work better for different cancers.
This observational study checks whether a blood test (a “cfDNA” test) can detect early signs of cancer or small amounts of cancer left after treatment. It may help doctors use a simple blood sample to improve cancer detection and follow-up.
This study tests a new way to find cancer by looking at DNA in blood, urine, and saliva. It may help detect cancer earlier and monitor how well treatment works.
This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.